Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Biodesix Inc., 3 years.
Biodesix Inc.
Director
Inhibrx Biosciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Inhibrx Biosciences Inc. | Open-market purchase | +5,000 | $100.00 | $500,000 |
| Sep 16, 2026 | Inhibrx Biosciences Inc. | Open-market purchase | +5,000 | $100.00 | $500,000 |
| Sep 8, 2026 | Inhibrx Biosciences Inc. | Open-market purchase | +5,000 | $113.52 | $567,580 |
| Mar 27, 2025 | Inhibrx Biosciences Inc. | Gift | โ90,000 | โ | โ |
| Dec 16, 2024 | Inhibrx Biosciences Inc. | Gift | โ500,000 | โ | โ |
| Dec 16, 2024 | Inhibrx Biosciences Inc. | Gift | +250,000 | โ | โ |
| Dec 16, 2024 | Inhibrx Biosciences Inc. | Gift | +250,000 | โ | โ |
| Dec 6, 2024 | Inhibrx Biosciences Inc. | Gift | โ52,000 | โ | โ |
| Nov 20, 2024 | Inhibrx Biosciences Inc. | Open-market purchase | +18,750 | $14.19 | $266,063 |
| Nov 20, 2024 | Inhibrx Biosciences Inc. | Open-market purchase | +18,750 | $14.19 | $266,063 |
| Nov 19, 2024 | Inhibrx Biosciences Inc. | Open-market purchase | +34,843 | $14.23 | $495,816 |
| Nov 19, 2024 | Inhibrx Biosciences Inc. | Open-market purchase | +34,843 | $14.23 | $495,816 |
| Jun 24, 2024 | Inhibrx Biosciences Inc. | Gift | โ89,050 | โ | โ |
| Jun 24, 2024 | Inhibrx Biosciences Inc. | Gift | +10,000 | โ | โ |
| Jun 24, 2024 | Inhibrx Biosciences Inc. | Gift | +10,000 | โ | โ |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.